Document is current
Any future updates will be listed below
-
Authors
von Deimling, Markus https://orcid.org/0000-0002-9954-3413
D’Andrea, David
Pradere, Benjamin
Laukhtina, Ekaterina
Yanagisawa, Takafumi
Kawada, Tatsushi
Majdoub, Muhammad
Rajwa, Pawel
Pallauf, Maximilian
Singla, Nirmish
Soria, Francesco
Margulis, Vitaly
Chlosta, Piotr
Karakiewicz, Pierre I.
Roupret, Morgan
Teoh, Jeremy Yuen-Chun
Fisch, Margit
Rink, Michael
Moschini, Marco
Lotan, Yair
Shariat, Shahrokh F.
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 20 January 2023
Accepted: 17 May 2023
First Online: 9 June 2023
Declarations
:
: MP reports that within the last 24 months, he received speaker honoraria from Astellas, and Janssen and travel support from Ipsen. SFS received as follows—Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, Takeda; Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Takeda; Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, Takeda. The other authors have no conflicts of interest to declare.
